1Department of Obstetrics and Gynecology, Zagreb University Hospital Centre, Zagreb, Croatia; 2School of Medicine, University of Zagreb, Zagreb, Croatia; 3Department of Obstetrics and Gynecology, Zadar General Hospital, Zadar, Croatia.
Acta Clin Croat. 2020 Dec;59(4):590-596. doi: 10.20471/acc.2020.59.04.04.
Pregnancy can alter the natural course of epilepsy and affect pharmacokinetic profile of antiepileptic drugs (AEDs) making therapeutic management more demanding. Since there is no relevant population-based study in Croatia to date, we conducted this research with the aim to observe antiepileptic treatment policy in pregnancy and to determine if the number of AEDs affects pregnancy outcomes. The study included all women with epilepsy with singleton pregnancy exposed to one or more AEDs divided into two groups (group 1: one AED and group 2: more than one AED used). Data were collected retrospectively at the Department of Obstetrics and Gynecology, Zagreb University Hospital Centre, Zagreb, Croatia, and included 153 women from January 2010 to December 2018. Primary outcomes included rates of preterm delivery, major fetal malformations, gestational hypertension, cesarean section rate, and appearance of seizures during pregnancy. We found higher rates of all pregnancy complications examined than in the general population, while comparison of the two study groups yielded significant differences. Preterm labor was detected in 30% of deliveries in polytherapy group compared to 16.6% in monotherapy group (p=0.03). Gestational hypertension was recorded in 20% of women in polytherapy group . 4.90% in monotherapy group (p=0.009). There was also a high rate of cesarean deliveries in polytherapy group (27.5%). Seizures during pregnancy occurred in 48.4% of patients in polytherapy group, which was significantly higher than the rate recorded in monotherapy group (p=0.015). In this single-center retrospective study, women with epilepsy using AEDs during pregnancy had a higher rate of gestational hypertension and preterm delivery than the general population of pregnant women. To the best of our knowledge, this is the first study in Croatia observing antiepileptic treatment policy in pregnancy with regards to AED regimen and perinatal outcome.
妊娠可能改变癫痫的自然病程,并影响抗癫痫药物(AEDs)的药代动力学特征,从而使治疗管理更加困难。由于迄今为止克罗地亚没有相关的基于人群的研究,我们进行了这项研究,旨在观察妊娠期间的抗癫痫治疗策略,并确定 AED 数量是否会影响妊娠结局。该研究纳入了所有接受一种或多种 AED 治疗的单胎妊娠癫痫女性,分为两组(组 1:一种 AED;组 2:使用一种以上 AED)。数据是在克罗地亚萨格勒布大学医院妇产科回顾性收集的,共纳入了 2010 年 1 月至 2018 年 12 月的 153 名女性。主要结局包括早产率、主要胎儿畸形、妊娠期高血压、剖宫产率和妊娠期癫痫发作率。我们发现,所检查的所有妊娠并发症的发生率均高于普通人群,而两组研究之间的比较存在显著差异。与单药组的 16.6%相比,多药组的早产率为 30%(p=0.03)。多药组中 20%的女性患有妊娠期高血压,而单药组中为 4.90%(p=0.009)。多药组的剖宫产率也很高(27.5%)。多药组中 48.4%的患者在妊娠期间出现癫痫发作,明显高于单药组(p=0.015)。在这项单中心回顾性研究中,与普通孕妇相比,使用 AED 治疗癫痫的孕妇妊娠期高血压和早产的发生率更高。据我们所知,这是克罗地亚首例观察妊娠期间 AED 方案和围产期结局的抗癫痫治疗策略的研究。